{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T23:01:43Z","timestamp":1781996503861,"version":"3.54.5"},"reference-count":35,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. vasc. bras."],"abstract":"<jats:p>Resumo O tromboembolismo venoso (TEV), que compreende o espectro de manifesta\u00e7\u00f5es de trombose venosa profunda e\/ou embolia pulmonar, \u00e9 uma complica\u00e7\u00e3o comum, grave e evit\u00e1vel em pacientes hospitalizados. Embora a perda da mobilidade recente ou continuada represente um dos principais fatores de risco relacionados ao desenvolvimento de TEV, n\u00e3o existem crit\u00e9rios claros e uniformes para a defini\u00e7\u00e3o do conceito de imobilidade. A diversidade dessas descri\u00e7\u00f5es dificulta a interpreta\u00e7\u00e3o e a compara\u00e7\u00e3o dos resultados de estudos cl\u00ednicos randomizados no que se refere \u00e0 influ\u00eancia dos diferentes n\u00edveis de imobilidade na magnitude do risco de TEV e ao papel da deambula\u00e7\u00e3o precoce, de forma isolada, na preven\u00e7\u00e3o de tais eventos. O entendimento dessas limita\u00e7\u00f5es \u00e9 mandat\u00f3rio para a utiliza\u00e7\u00e3o e interpreta\u00e7\u00e3o adequadas das ferramentas de avalia\u00e7\u00e3o de risco de TEV, e para a indica\u00e7\u00e3o da melhor estrat\u00e9gia de preven\u00e7\u00e3o de trombose em pacientes cl\u00ednicos hospitalizados. O objetivo deste estudo \u00e9 revisar as principais evid\u00eancias da literatura quanto ao papel da deambula\u00e7\u00e3o na preven\u00e7\u00e3o do TEV.<\/jats:p>","DOI":"10.1590\/1677-5449.180107","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T19:34:02Z","timestamp":1562182442000},"source":"Crossref","is-referenced-by-count":14,"title":["Papel da deambula\u00e7\u00e3o na preven\u00e7\u00e3o do tromboembolismo venoso em pacientes cl\u00ednicos: onde estamos?"],"prefix":"10.1590","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-9221","authenticated-orcid":false,"given":"Maria Chiara","family":"Chindamo","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio de Janeiro,  Brasil; Rede D\u2019Or S\u00e3o Luiz, Hospital Barra D\u2019Or,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-7819","authenticated-orcid":false,"given":"Marcos Ar\u00eaas","family":"Marques","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro,  Brasil; Universidade Federal do Estado do Rio de Janeiro,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019]]},"reference":[{"issue":"6778","key":"ref1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bmj.302.6778.709","article-title":"Incidence of venous thromboembolism verified by necropsy over 30 years","volume":"302","author":"Lindblad B","year":"1991","journal-title":"BMJ"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/jcp.2003.013581","article-title":"Fatal pulmonary embolism in hospitalized patients: a necropsy review","volume":"57","author":"Alikhan R","year":"2004","journal-title":"J Clin Pathol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn SR","year":"2012","journal-title":"Chest"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1742-1241.2010.02447.x","article-title":"The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients","volume":"64","author":"Dobesh P","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1532-5415.2004.52359.x","article-title":"Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study","volume":"52","author":"Weill-Engerer S","year":"2004","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"ref6","first-page":"293","article-title":"Venous thromboembolism prophylaxis in pregnancy","volume":"15","author":"Oliveira ALML","year":"2016","journal-title":"J Vasc Bras"},{"issue":"5","key":"ref7","first-page":"955","article-title":"Does ambulation modify venous thromboembolism risk in acutely ill medical patients?","volume":"104","author":"Amin AN","year":"2010","journal-title":"Thromb Haemost"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-153-1-201007060-00004","article-title":"Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial","volume":"153","author":"Hull RD","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref9","first-page":"47","article-title":"Risk factor assessment in the management of patients with suspected deep venous thrombosis","volume":"19","author":"Motykie GD","year":"2000","journal-title":"Int Angiol"},{"issue":"22","key":"ref10","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama MM","year":"2000","journal-title":"Arch Intern Med"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit JA","year":"2000","journal-title":"Arch Intern Med"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1076029616677802","article-title":"Variation in definitions of immobility in pharmacological thromboprophylaxis clinical trials in medical inpatients: a systematic review","volume":"24","author":"Ye F","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1076029612452781","article-title":"Relevance of immobility and importance of risk assessment management for medically ill patients","volume":"19","author":"Hull RD","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref14","first-page":"49","article-title":"The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy\/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group","volume":"26","author":"Lechler E","year":"1996","journal-title":"Haemostasis"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1067\/mhj.2003.189","article-title":"Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease","volume":"145","author":"Kleber FX","year":"2003","journal-title":"Am Heart J"},{"issue":"7537","key":"ref16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo-controlled trial","volume":"332","author":"Cohen AT","year":"2006","journal-title":"BMJ"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz A","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama MM","year":"1999","journal-title":"N Engl J Med"},{"issue":"9610","key":"ref19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"371","author":"Cohen AT","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"ref20","first-page":"258","article-title":"Venous thromboprophylaxis in medical patients: an application review","volume":"59","author":"Kerbauy MN","year":"2013","journal-title":"Rev Assoc Med Bras"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1160\/TH16-08-0631","article-title":"Risk assessment models for venous thromboembolism in acutely ill medical patients: a systematic review","volume":"117","author":"Stuck AK","year":"2017","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar S","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and associative models to identify hospitalized medical patients at risk for VTE","volume":"140","author":"Spyropoulos AC","year":"2011","journal-title":"Chest"},{"issue":"4","key":"ref24","first-page":"533","article-title":"Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients","volume":"3","author":"Rocha AT","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3810\/hp.2010.06.311","article-title":"Lack of thromboprophylaxis across the care continuum in US medical patients","volume":"38","author":"Amin A","year":"2010","journal-title":"Hosp Pract"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jhm.1002","article-title":"Duration of venous thromboembolism risk across a continuum in medically Ill hospitalized patients","volume":"7","author":"Amin AN","year":"2012","journal-title":"J Hosp Med"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1076029613481105","article-title":"Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors","volume":"19","author":"Hull RD","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11239-011-0549-x","article-title":"Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol","volume":"31","author":"Cohen AT","year":"2011","journal-title":"J Thromb Thrombolysis"},{"issue":"23","key":"ref29","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1110899","article-title":"Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients","volume":"365","author":"Goldhaber SZ","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","article-title":"Extended thromboprophylaxis with betrixaban in acutely Ill medical patients","volume":"375","author":"Cohen AT","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1160\/TH15-09-0756","article-title":"The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE: design, rationale, and clinical implications","volume":"115","author":"Raskob GE","year":"2016","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMoa1805090","article-title":"Rivaroxaban for thromboprophylaxis after hospitalization for medical illness","volume":"379","author":"Spyropoulos AC","year":"2018","journal-title":"N Engl J Med"},{"key":"ref33","article-title":"Developing a mobility protocol for early mobilization of patients in a surgical\/trauma ICU","volume":"2012","author":"Zomorodi M","year":"2012","journal-title":"Crit Care Res Pract"},{"issue":"6S","key":"ref34","first-page":"S11","article-title":"Early ambulation and prevention of post-operative thromboembolic risk","volume":"153","author":"Talec P","year":"2016","journal-title":"J Vasc Surg"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/NUR.0b013e31824590e6","article-title":"Impact of early mobilization protocol on the medical-surgical inpatient population: an integrated review of literature","volume":"26","author":"Pashikanti L","year":"2012","journal-title":"Clin Nurse Spec"}],"container-title":["Jornal Vascular Brasileiro"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jvb\/v18\/1677-5449-jvb-18-e20180107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T20:29:44Z","timestamp":1581107384000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-54492019000100406&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":35,"alternative-id":["S1677-54492019000100406"],"URL":"https:\/\/doi.org\/10.1590\/1677-5449.180107","relation":{},"ISSN":["1677-7301","1677-5449"],"issn-type":[{"value":"1677-7301","type":"electronic"},{"value":"1677-5449","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e20180107"}}